Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

BACKGROUND: Dose-dense sequential chemotherapy including anthracyclines and taxanes has been established in the adjuvant setting of high-risk operable breast cancer. However, the preferable taxane and optimal schedule of administration in a dose-dense regimen have not been defined yet. METHODS: From...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Fountzilas, George, Dafni, Urania, Papadimitriou, Christos, Timotheadou, Eleni, Gogas, Helen, Eleftheraki, Anastasia G, Xanthakis, Ioannis, Christodoulou, Christos, Koutras, Angelos, Papandreou, Christos N, Papakostas, Pavlos, Miliaras, Spyros, Markopoulos, Christos, Dimitrakakis, Constantine, Korantzopoulos, Panagiotis, Karanikiotis, Charisios, Bafaloukos, Dimitrios, Kosmidis, Paris, Samantas, Epaminontas, Varthalitis, Ioannis, Pavlidis, Nicholas, Pectasides, Dimitrios, Dimopoulos, Meletios-Athanassios
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223601/
https://ncbi.nlm.nih.gov/pubmed/25026897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-515
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky